Effectiveness of Erector Spinae Block in Kyphoplasty
Sponsored by Gulhane School of Medicine
About this trial
Last updated 5 years ago
Study ID
19/341
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
40 to 80 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
As of October 2019, when the investigators received the approval of the ethics committee,
patients who were decided to undergo kyphoplasty with vertebral compression fracture will be
included in the study. The patients will be divided into three groups according to the
anesthetic method as conventional local anesthesia infiltration (CLIA) method and
extrapedicular infiltration anesthesia (EPIAA) and 30 other patients as US guided erector
spina group (ESP) for a total of 60 patients. The degree of pain in the intraoperative period
will be assessed using a numerical rating scale. Patients with severe pain (NRS> 4) will
receive 50 micrograms of fentanyl as an additional analgesic. Sedation levels of the patients
will be evaluated with ramsey sedation scale (1-6). Patients with a sedation score of 1 will
receive 2 mg of midazolam. During the procedure, pain scores at 0 minutes, 15, 30 and 45
minutes, sedation scores, additional analgesic and sedation amounts administered, and
hemodynamic parameters will be recorded. The statistical difference between the groups will
be compared
What are the participation requirements?
Inclusion Criteria
- The American Society of Anesthesiologists (ASA) score I-III
- 40-80 years old
Exclusion Criteria
- ASA >III,
- receiving chronic pain treatment
- previous lumbar surgery